santa cruz biotechnology, inc.

| |
|
| | Tachykinins
- MEN10376
EN10376 is a Tachykinin (neurokinin 2 (NK2)) receptor antagonist that is used in a variety of neurokinin receptors studies.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201172 | 135306-85-3 | C57H68N12O10 | 1 mg |
- Neurokinin A
An endogenous tachykinin agonist with preference for the NK-2 receptor, and more potent bronchoconstrictor than Substance P.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201171 | 86933-74-6 | C50H80N14O14S | 1 mg |
- Neurokinin B
Neurokinin B is a tachykinin, and functions as a neuromodulator or a neurotransmitter. It has been reported to induce interleukin (IL)-1 or IL-2-like activity.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201173 | 86933-75-7 | C55H79N13O14S2 | 1 mg |
- [Sar-9, Met(O2)-11]-Substance P
A highly selective NK-1 neurokinin receptor agonist which stimulates endocytosis of NK-1 receptors but has minimal effect on NK-3 receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201170 | 110880-55-2 | C64H100N18O15S | 1 mg |
- Senktide
Shown to be a tachykinin NK-3R agonist which may cause bronchoconstriction in guinea pig lungs. Also has been reported to induce increased numbers of Fos-LI neurons.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201174 | 106128-89-6 | C40H55N7O11S | 1 mg/5 mg |
- Substance P
A neurokinin neurotransmitter, which is characterized by the C-terminal sequence, Phe-X-Gly-Leu-Met-NH22. A key factor in cancer cell proliferation and that inhibition of this component can induce apoptosis in cancer cells and decrease the steady state of Her2 and EGFR.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201169 | 33507-63-0 | C63H98N18O13S | 1 mg |
|